The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial

[1]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[2]  T. Gislason,et al.  Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression , 2005, European Respiratory Journal.

[3]  M. Decramer,et al.  Management of COPD according to guidelines. A national survey among Belgian physicians. , 2003, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[4]  M. Panella,et al.  Reducing clinical variations with clinical pathways: do pathways work? , 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[5]  D. Berwick.  The science of improvement. , 2008, JAMA.

[6]  Fadhel Kaboub.  Realistic Evaluation , 2004 .

[7]  J. Garcia-Aymerich,et al.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study , 2003, Thorax.

[8]  D. Forman,et al.  Delays in managing lung cancer. , 2004, Thorax.

[9]  Pedro Almagro,et al.  Risk Factors for Hospital Readmission in Patients with Chronic Obstructive Pulmonary Disease , 2006, Respiration.

[10]  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.

[11]  K. McDonald,et al.  Making health care safer: a critical analysis of patient safety practices. , 2001, Evidence report/technology assessment.

[12]  N. Santamaria,et al.  A prospective cohort study of the effectiveness of clinical pathways for the in-patient management of acute exacerbation of chronic obstructive pulmonary disease (COPD) , 2004 .

[13]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[14]  M. Panella,et al.  Reducing stroke in-hospital mortality: organized care is a complex intervention. , 2008, Stroke.

[15]  Thomas Rotter,et al.  Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. , 2010, The Cochrane database of systematic reviews.

[16]  C. Roberts,et al.  Evidence for a link between mortality in acute COPD and hospital type and resources , 2003, Thorax.

[17]  M. Panella,et al.  A cluster randomized controlled trial of a clinical pathway for hospital treatment of heart failure: study design and population , 2007, BMC Health Services Research.

[18]  Antonella Barbieri,et al.  A cluster randomized trial to assess the impact of clinical pathways for patients with stroke: rationale and design of the Clinical Pathways for Effective and Appropriate Care Study [NCT00673491] , 2008, BMC Health Services Research.

[19]  P. Sandercock,et al.  Framework for design and evaluation of complex interventions to improve health , 2000, BMJ : British Medical Journal.

[20]  Emiel F M Wouters,et al.  Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. , 2003, Chest.

[21]  M. Leal,et al.  Study of the burden on patients with chronic obstructive pulmonary disease , 2009, International journal of clinical practice.

[22]  Thomas Lee,et al.  Critical Pathways as a Strategy for Improving Care: Problems and Potential , 1995, Annals of Internal Medicine.

[23]  E. R. Sutherland,et al.  Management of chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[24]  A FRAMEWORK FOR DEVELOPMENT AND EVALUATION OF RCTs FOR COMPLEX INTERVENTIONS TO IMPROVE HEALTH , 2000 .

[25]  D. Cullen,et al.  Long term oxygen therapy adherence and COPD: what we don't know , 2006, Chronic respiratory disease.

[26]  T. McManus,et al.  The Mater Hospital Multiprofessional Care Pathway for Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2005 .

[27]  J. D. de Miguel-Yanes,et al.  Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. , 2007, The American journal of emergency medicine.

[28]  H. Campbell,et al.  Integrated care pathways , 1998, BMJ.

[29]  Alan Shiell,et al.  Complex interventions: how “out of control” can a randomised controlled trial be? , 2004, BMJ : British Medical Journal.

[30]  Kris Vanhaecht,et al.  Is there still need for confusion about pathways? , 2010 .

[31]  L. Manzoli,et al.  Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial , 2009, Quality and Safety in Health Care.

[32]  M. Decramer,et al.  Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines. , 2009, Journal of evaluation in clinical practice.

[33]  M. Pearson,et al.  Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease , 2002, Thorax.

[34]  T. Seemungal,et al.  Exacerbation rate, health status and mortality in COPD – a review of potential interventions , 2009, International journal of chronic obstructive pulmonary disease.

[35]  K Farley.  The COPD Critical Pathway: A Case Study in Progress , 1995, Quality management in health care.

[36]  J. Wedzicha,et al.  Management of acute exacerbation of chronic obstructive pulmonary disease , 2006 .

[37]  A. Yohannes,et al.  Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. , 2005, Age and ageing.

[38]  K. Vanhaecht.  The impact of clinical pathways on the organisation of care processes , 2007 .

[39]  Alexander Rokitansky,et al.  Thorax , 2009, Pediatric Surgery Digest.

[40]  K Vanhaecht,et al.  Effects of clinical pathways in the joint replacement: a meta-analysis , 2009, BMC medicine.

[41]  P. Eng,et al.  Frequent hospital readmissions for acute exacerbation of COPD and their associated factors , 2006, Respirology.

[42]  J. L. Rau.  Determinants of patient adherence to an aerosol regimen. , 2005, Respiratory care.

[43]  R. Rodríguez-Roisín,et al.  COPD exacerbations · 5: Management , 2006, Thorax.

[44]  Elizabeth Allen,et al.  Process evaluation in randomised controlled trials of complex interventions , 2006, BMJ : British Medical Journal.

[45]  Kris Vanhaecht,et al.  Care Pathways are defined as complex interventions , 2010 .

[46]  K. Zander,et al.  Prevalence and use of clinical pathways in 23 countries – an international survey by the European Pathway Association , 2006 .

[47]  Kathleen A Bower,et al.  Clinical pathways: 12 lessons learned over 25 years of experience , 2009 .

[48]  E. Pehlivan,et al.  Factors affecting survival of hospitalised patients with COPD , 2005, European Respiratory Journal.

[49]  P. Gold,et al.  The 2007 GOLD Guidelines: a comprehensive care framework. , 2009, Respiratory care.

[50]  K. Vanhaecht,et al.  The European Quality of Care Pathway (EQCP) Study: history, project management and approach , 2010 .

[51]  B. Rubin,et al.  Problems with inhaler use: a call for improved clinician and patient education. , 2005, Respiratory care.